Skip to main content
Article thumbnail
Location of Repository

Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

By Martijn van Essen, Eric P. Krenning, Boen L. Kam, Wouter W. de Herder, Maarten O. van Aken and Dik J. Kwekkeboom
Topics: Original Article
Publisher: Springer-Verlag
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. [177Lu-DOTA0Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients.
    2. A phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    3. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
    4. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    5. (1998). Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.
    6. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
    7. High-dose In-111 octreotide therapy in combination with radiosensitizing 5-FU chemotherapy for treatment of SSR-expressing neuroendocrine tumors.
    8. Phase I study of peptide receptor radionuclide therapy with [ 111In-DTPA 0]Octreotide: the Rotterdam experience.
    9. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched pair analysis.
    10. (2005). Treatment with the radiolabeled somatostatin analogue [ 177Lu-DOTA 0,Tyr 3]octreotate in patients with gastro-entero-pancreatic (GEP) tumors.
    11. (2008). X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 1999;5:2948–53. 748 Eur J Nucl Med Mol Imaging

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.